ISLET ALLO TRANSPLANTATION
IN PATIENTS WITH KIDNEY GRAFT
Pancreatic Islet Allo Transplantation
in Patients with Stable Kidney Graft Function
Information for Patients,
I am writing to let you know about an opportunity to participate in a research study designed for patients with Type 1 Diabetes. This study is being conducted by myself, Dr. Piotr Witkowski at the University of Chicago.
This research study will assess the safety, tolerability and efficacy of the Sernova Cell Pouch™ that will be implanted under the skin, and transplanted with human pancreatic islets.
You may be eligible for this study if:
you are between the ages of 18-65,
have been diagnosed with Type 1 Diabetes for longer than 5 years,
suffer from sudden and unpredictable drops of blood glucose leading to confusion or passing out despite the best medical treatment of insulin under the guidance of an experienced diabetologist.
If you are interested in learning more about this study, please review "Brief description" and "the patient information sheet" and contact Lindsay Basto, RN, BSN, Lindsay.Basto@uchicago.edu or 773-702-2504, for more information.
It is important to know that this letter is not to tell you to join the study.
It is your decision, and your participation is voluntary.
Whether you show interest, and participate in the study or not, it will have no effect on your treatment with your doctors.
Thank you for your interest and consideration,
Piotr Witkowski M.D. Ph.D